Convatec Wound

Post-operative healing requires appropriate dressing use. Foam Lite™ is a thin dressing with a breathable film and perforated, gentle, skin friendly silicone adhesive. It is flexible and conforms [2] to the body even in awkward to dress positions, [2] which is why it is effective in managing surgical wounds as assessed by both patients and surgeons. [1] Read more about Foam Lite™ dressings and order a sample at https://brnw.ch/21wS4UV References 1.Orlandini, V et al. A New Hydrocellular Wound Dressing Used After Dermatologic Surgery: Dermatologic Surgeons' and Patients' Perceptions” 2020 Dermatologic Surgery 46(9):p e53e59, September 2020. 2. In vitro Performance of Foam Lite ConvaTecWHRI4680 MS132. Data on file, Convatec 25th April 2016.

Did you know that Nitric Oxide (NO) blocks bacterial communication? Visit our new NO webpage here: https://brnw.ch/21wRW0V Bacteria communicate by releasing messenger molecules, called quorum sensing molecules, which instruct neighbouring bacteria to change their behaviour. NO blocks these quorum sensing molecules resulting in: · increased susceptibility to antimicrobials · reduced aggregation · reduced motility Reference: Heckler I, Boon EM. Insights Into Nitric Oxide Modulated Quorum Sensing Pathways. Frontiers in Microbiology 2019; 10: 2174.

Diabetic Foot Ulcers (DFU's) pose a significant clinical challenge, resulting in poor patient quality of life and substantial economic burden [1,2]. These wounds can have complex biofilms that contribute to wound chronicity, delayed healing and increased infection risk due to the protection of microbes from the host immune system, local and systemic antimicrobial agents [3,4,5] Nitric Oxide(NO) is a natural, broad range antimicrobial produced in response to infection as part of the inflammatory response.6,7 The unique antimicrobial properties of NO, with there being no demonstrated resistance and its combined activity against biofilm, giving the promise of improving wound care and patient outcomes.8, 9 Read more here: https://brnw.ch/21wRU2r

Nitric Oxide's (NO) antimicrobial action stems from its ability to penetrate microbial cells where it exerts a combination of actions working in synergy to kill the bacteria. Learn more about the antimicrobial action of Nitric Oxide here https://brnw.ch/21wRR16

Polymicrobial communities within hard-to-heal wounds form complex biofilms that contribute to wound chronicity, delayed healing and increased infection risk[1].  Want to find out more about how Nitric Oxide(NO) can target specific mechanisms that are integral to biofilm survival. Read more here: https://brnw.ch/21wRPGM Reference:1. Percival SL, McCarty SM, Lipsky B. Biofilms and Wounds: An Overview of the Evidence. Adv Wound Care (New Rochelle) 2015;4:373-381

99% of HCPs who took part in our #WoundHygieneChallenge will continue to adopt the #WoundHygiene protocol of care. #BeSureinFour [n=685/693] Missed us at #EWMA2025? Want to find out more about the practical change management process that elevates clinician knowledge and skills of biofilm based wound care? Visit https://brnw.ch/21wRNjo gb/advanced-wound-care/events/ewma/ Reference: Metcalf D, Torkington-Stokes R. Convatec Data on file: AWC-2024-015 Wound Hygiene Challenge: Qualitative responses on use of product and Wound Hygiene protocol. RPT-074809. 04 April 2024.

Diabetes is the disease that contributes to the greatest number of diagnosed chronic wounds. [1] The global prevalence of diabetes increases every year. This increase is so fast that diabetes is now considered by the World Health Organisation (WHO) as a global fast-growing epidemic. [2] People with diabetes are especially prone to developing Diabetic Foot Ulcers (DFUs) [1], with infection being the most common, severe and costly complication, with high risk of mortality and morbidity due to lower limb amputation. [3] Explore our latest technology to discover a new potential way to manage DFUs: https://brnw.ch/21wRMFp 1. Malone-Povolny MJ, Maloney SE, Schoenfisch MH. Nitric Oxide Therapy for Diabetic Wound Healing. Adv Healthc Mater. 2019;8(12):e1801210. doi:10.1002/adhm.201801210. 2. Afonso, A.C., Oliveira, D., Saavedra, M.J., Borges, A., Simões, M. Biofilms in Diabetic Foot Ulcers: Impact, Risk Factors and Control Strategies. Int J Mol Sci. 2021, 22, 8278. https://brnw.ch/21wRMFq.

The big loss such as an amputation can often start small, with a simple missed wound. But by knowing how to manage Diabetic Foot Ulcers, we have the power to help to prevent amputation. Learn more here: https://brnw.ch/21wRLCd

The big loss such as an amputation can often start small, with a simple missed wound. But by knowing how to manage Diabetic Foot Ulcers, we have the power to help to prevent amputation. Learn more here … https://brnw.ch/21wRIgi

We listened, innovated, and designed a better care experience by redefining what a foam dressing can do. MISSED OUR #EWMA2025 symposium: 'Redefining Foam Dressings; delivering innovation to improve patient care' You can find out more and try new ConvaFoam™ superior performance*1 today: https://brnw.ch/21wRHap Reference: *vs selected dressings tested in vitro for absorption, retention, fluid handling and adhesion. 1. WHRI9478 MS186_DHF1093 ConvaFoam Superiority Report Testing between May 2021 – June 2022.